Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2011
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer
M D Michaelson, J Bellmunt, G R Hudes, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
The <i>Endo-GeneScreen</i> Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
Nature Communications
|
December 9, 2025
The Endo-GeneScreen platform identifies drug-like probes that regulate endogenous protein levels within physiological contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
British Journal of Cancer
|
May 15, 2014
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
B Escudier, M D Michaelson, R J Motzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2023
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
B A McGregor, G P Sonpavde, L Kwak, et al.
European Urology
|
January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Nicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2021
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors
Harish Seethapathy, Sarah Street, Ian Strohbehn, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2011
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer
M D Michaelson, J Bellmunt, G R Hudes, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
The <i>Endo-GeneScreen</i> Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
Nature Communications
|
December 9, 2025
The Endo-GeneScreen platform identifies drug-like probes that regulate endogenous protein levels within physiological contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
British Journal of Cancer
|
May 15, 2014
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial
B Escudier, M D Michaelson, R J Motzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 23, 2023
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma
B A McGregor, G P Sonpavde, L Kwak, et al.
European Urology
|
January 14, 2017
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
Nicholas J Giacalone, William U Shipley, Rebecca H Clayman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 5, 2021
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors
Harish Seethapathy, Sarah Street, Ian Strohbehn, et al.
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward
L C Harshman, C G Drake, N B Haas, et al.
Page
of 6